MONTREAL, QUEBEC--(Marketwire - March 18, 2008) - Ambrilia Biopharma Inc. (TSX: AMB) announced today that it will be hosting a conference call and webcast on Tuesday, March 25, 2008, at 9:00 am ET, to discuss the financial results for the fourth quarter and fiscal year ended December 31, 2007, and provide a review of its development programs and milestones. Prior to the conference call, a press release will be issued on Monday, March 24, 2008, after market close. The call will be hosted by Dr. Philippe Calais, President and Chief Executive Officer, Ambrilia, and Ms. Monique Letourneau, Executive Vice-President, Finance and Chief Financial Officer, Ambrilia.
